ENSG00000175344


Homo sapiens

Features
Gene ID: ENSG00000175344
  
Biological name :CHRNA7
  
Synonyms : cholinergic receptor nicotinic alpha 7 subunit / CHRNA7 / P36544
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 15
Strand: 1
Band: q13.3
Gene start: 31923438
Gene end: 32173018
  
Corresponding Affymetrix probe sets: 210123_s_at (Human Genome U133 Plus 2.0 Array)   236385_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000489825
Ensembl peptide - ENSP00000407546
Ensembl peptide - ENSP00000489657
Ensembl peptide - ENSP00000489834
Ensembl peptide - ENSP00000490924
Ensembl peptide - ENSP00000490906
Ensembl peptide - ENSP00000490778
Ensembl peptide - ENSP00000490773
Ensembl peptide - ENSP00000490605
Ensembl peptide - ENSP00000490590
Ensembl peptide - ENSP00000490526
Ensembl peptide - ENSP00000490513
Ensembl peptide - ENSP00000490413
Ensembl peptide - ENSP00000490366
Ensembl peptide - ENSP00000490365
Ensembl peptide - ENSP00000490346
Ensembl peptide - ENSP00000490227
Ensembl peptide - ENSP00000490215
Ensembl peptide - ENSP00000490015
Ensembl peptide - ENSP00000489970
Ensembl peptide - ENSP00000489919
Ensembl peptide - ENSP00000489911
Ensembl peptide - ENSP00000303727
Ensembl peptide - ENSP00000399087
NCBI entrez gene - 1139     See in Manteia.
NCBI entrez gene - 101929970     See in Manteia.
OMIM - 118511
RefSeq - XM_017021884
RefSeq - NM_000746
RefSeq - NM_001190455
RefSeq - XM_011508492
RefSeq - XM_011521176
RefSeq - XM_011521177
RefSeq - XM_011521178
RefSeq - XM_016999550
RefSeq - XM_017021882
RefSeq - XM_017021883
RefSeq Peptide - NP_001177384
RefSeq Peptide - NP_000737
swissprot - A0A1B0GUR5
swissprot - A0A1B0GU93
swissprot - A0A1B0GU56
swissprot - A0A1B0GU11
swissprot - A0A1B0GU04
swissprot - A0A1B0GTT9
swissprot - A0A1B0GTT0
swissprot - P36544
swissprot - A0A1B0GTE0
swissprot - A0A1B0GWH1
swissprot - A0A1B0GW52
swissprot - A0A1B0GW47
swissprot - A0A1B0GVP9
swissprot - A0A1B0GVN6
swissprot - A0A1B0GVI5
swissprot - A0A1B0GVH2
swissprot - A0A1B0GV86
swissprot - A0A1B0GV43
swissprot - A0A1B0GV44
swissprot - A0A1B0GV25
Ensembl - ENSG00000175344
  
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 chrna7ENSDARG00000101702Danio rerio
 FO907089.1ENSDARG00000101522Danio rerio
 CHRNA7ENSGALG00000004096Gallus gallus
 Chrna7ENSMUSG00000030525Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
Q494W8 / CHRFAM7A / CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusionENSG0000016666473
Q9GZZ6 / CHRNA10 / cholinergic receptor nicotinic alpha 10 subunitENSG0000012974934
CHRNA9 / Q9UGM1 / cholinergic receptor nicotinic alpha 9 subunitENSG0000017434331
CHRND / Q07001 / cholinergic receptor nicotinic delta subunitENSG0000013590230
CHRNG / P07510 / cholinergic receptor nicotinic gamma subunitENSG0000019681129
CHRNB1 / P11230 / cholinergic receptor nicotinic beta 1 subunitENSG0000017017529
CHRNE / Q04844 / cholinergic receptor nicotinic epsilon subunitENSG0000010855627
HTR3A / P46098 / 5-hydroxytryptamine receptor 3AENSG0000016673624
HTR3C / Q8WXA8 / 5-hydroxytryptamine receptor 3CENSG0000017808421
HTR3E / A5X5Y0 / 5-hydroxytryptamine receptor 3EENSG0000018603820
HTR3B / O95264 / 5-hydroxytryptamine receptor 3BENSG0000014930519
HTR3D / Q70Z44 / 5-hydroxytryptamine receptor 3DENSG0000018609016


Protein motifs (from Interpro)
Interpro ID Name
 IPR002394  Nicotinic acetylcholine receptor
 IPR006029  Neurotransmitter-gated ion-channel transmembrane domain
 IPR006201  Neurotransmitter-gated ion-channel
 IPR006202  Neurotransmitter-gated ion-channel ligand-binding domain
 IPR018000  Neurotransmitter-gated ion-channel, conserved site
 IPR036719  Neurotransmitter-gated ion-channel transmembrane domain superfamily
 IPR036734  Neurotransmitter-gated ion-channel ligand-binding domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0000187 activation of MAPK activity IDA
 biological_processGO:0001666 response to hypoxia IDA
 biological_processGO:0001933 negative regulation of protein phosphorylation IEA
 biological_processGO:0001934 positive regulation of protein phosphorylation ISS
 biological_processGO:0001988 positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure IEA
 biological_processGO:0006811 ion transport IEA
 biological_processGO:0006816 calcium ion transport IMP
 biological_processGO:0006874 cellular calcium ion homeostasis IMP
 biological_processGO:0006897 endocytosis IEA
 biological_processGO:0007165 signal transduction IEA
 biological_processGO:0007271 synaptic transmission, cholinergic IEA
 biological_processGO:0007611 learning or memory ISS
 biological_processGO:0007613 memory ISS
 biological_processGO:0007614 short-term memory ISS
 biological_processGO:0008284 positive regulation of cell proliferation IMP
 biological_processGO:0008306 associative learning IEA
 biological_processGO:0009409 response to cold IEA
 biological_processGO:0014061 regulation of norepinephrine secretion IEA
 biological_processGO:0030317 flagellated sperm motility IEA
 biological_processGO:0032094 response to food IEA
 biological_processGO:0032225 regulation of synaptic transmission, dopaminergic IEA
 biological_processGO:0032691 negative regulation of interleukin-1 beta production IEA
 biological_processGO:0032715 negative regulation of interleukin-6 production IEA
 biological_processGO:0032720 negative regulation of tumor necrosis factor production IDA
 biological_processGO:0033138 positive regulation of peptidyl-serine phosphorylation IEA
 biological_processGO:0034220 ion transmembrane transport IEA
 biological_processGO:0035094 response to nicotine ISS
 biological_processGO:0035095 behavioral response to nicotine IEA
 biological_processGO:0042110 T cell activation IEA
 biological_processGO:0042113 B cell activation IEA
 biological_processGO:0042391 regulation of membrane potential IEA
 biological_processGO:0042698 ovulation cycle IEA
 biological_processGO:0045471 response to ethanol IEA
 biological_processGO:0045766 positive regulation of angiogenesis IMP
 biological_processGO:0048149 behavioral response to ethanol IEA
 biological_processGO:0050727 regulation of inflammatory response IEA
 biological_processGO:0050728 negative regulation of inflammatory response IEA
 biological_processGO:0050804 modulation of chemical synaptic transmission IEA
 biological_processGO:0050808 synapse organization ISS
 biological_processGO:0050890 cognition NAS
 biological_processGO:0050893 sensory processing ISS
 biological_processGO:0051247 positive regulation of protein metabolic process ISS
 biological_processGO:0060078 regulation of postsynaptic membrane potential IEA
 biological_processGO:0060079 excitatory postsynaptic potential IEA
 biological_processGO:0060112 generation of ovulation cycle rhythm IEA
 biological_processGO:0070374 positive regulation of ERK1 and ERK2 cascade ISS
 biological_processGO:0070588 calcium ion transmembrane transport IEA
 biological_processGO:0095500 acetylcholine receptor signaling pathway ISS
 biological_processGO:0097061 dendritic spine organization ISS
 biological_processGO:0098815 modulation of excitatory postsynaptic potential ISS
 biological_processGO:0140059 dendrite arborization ISS
 biological_processGO:1900273 positive regulation of long-term synaptic potentiation ISS
 biological_processGO:1901214 regulation of neuron death ISS
 biological_processGO:1902004 positive regulation of amyloid-beta formation ISS
 biological_processGO:1902430 negative regulation of amyloid-beta formation IGI
 biological_processGO:1902991 regulation of amyloid precursor protein catabolic process IGI
 biological_processGO:1904645 response to amyloid-beta ISS
 biological_processGO:1905144 response to acetylcholine ISS
 biological_processGO:1905906 regulation of amyloid fibril formation ISS
 biological_processGO:1905920 positive regulation of CoA-transferase activity ISS
 biological_processGO:2000463 positive regulation of excitatory postsynaptic potential ISS
 cellular_componentGO:0005886 plasma membrane IEA
 cellular_componentGO:0005892 acetylcholine-gated channel complex IDA
 cellular_componentGO:0009897 external side of plasma membrane IEA
 cellular_componentGO:0016020 membrane IEA
 cellular_componentGO:0016021 integral component of membrane IEA
 cellular_componentGO:0016324 apical plasma membrane IEA
 cellular_componentGO:0030054 cell junction IEA
 cellular_componentGO:0030673 axolemma IEA
 cellular_componentGO:0044853 plasma membrane raft ISS
 cellular_componentGO:0045202 synapse IEA
 cellular_componentGO:0045211 postsynaptic membrane IEA
 cellular_componentGO:0098794 postsynapse TAS
 molecular_functionGO:0001540 amyloid-beta binding IPI
 molecular_functionGO:0004888 transmembrane signaling receptor activity IEA
 molecular_functionGO:0005216 ion channel activity IEA
 molecular_functionGO:0005230 extracellular ligand-gated ion channel activity IEA
 molecular_functionGO:0005262 calcium channel activity TAS
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0015276 ligand-gated ion channel activity TAS
 molecular_functionGO:0015464 acetylcholine receptor activity IDA
 molecular_functionGO:0015643 toxic substance binding IDA
 molecular_functionGO:0017081 chloride channel regulator activity IDA
 molecular_functionGO:0022848 acetylcholine-gated cation-selective channel activity IEA
 molecular_functionGO:0042166 acetylcholine binding IDA
 molecular_functionGO:0042803 protein homodimerization activity IDA


Pathways (from Reactome)
Pathway description
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000252 Microcephaly "Microcephaly is a neurodevelopmental disorder in which the circumference of the head is more than two standard deviations smaller than the age- and gender-dependent norm." [HPO:curators]
Show

 HP:0000256 Macrocephaly "The presence of an abnormally large `skull` (FMA:46565)." [HPO:probinson]
Show

 HP:0000286 Epicanthus "An epicanthal fold is a semilunar fold of skin that extends from the upper eyelid across the medial canthal area to the lower eyelid." [HPO:curators]
Show

 HP:0000316 Hypertelorism 
Show

 HP:0000377 Abnormal form of ears "Abnormal form of the out part of the ear (also referred to as the auricle or pinna)." [HPO:curators]
Show

 HP:0000400 Large ears 
Show

 HP:0000411 Protruding ears 
Show

 HP:0000486 Strabismus "Strabismus (also known as squint) is a condition in which the eyes are not properly aligned with each other." [HPO:curators]
Show

 HP:0000494 Downward slanting palpebral fissures 
Show

 HP:0000664 Synophrys "Fusion of the left and right `eyebrow` (FMA:54237)." [HPO:probinson]
Show

 HP:0000708 Behavioural/Psychiatric Abnormality 
Show

 HP:0000717 Autism 
Show

 HP:0000995 Pigmented nevi "The presence of increased numbers of pigmented nevi, that is, of small, dark spots on the skin. Pigmented nevi are also known as melanocytic nevi or moles." [HPO:curators]
Show

 HP:0001156 Brachydactyly 
Show

 HP:0001249 Mental retardation 
Show

 HP:0001250 Seizures "Seizures are an intermittent `abnormality of the central nervous system` (FMA:HP:0002011) due to a sudden, excessive, disorderly discharge of cerebral neurons and characterized clinically by some combination of disturbance of sensation, loss of consciousness, impairment of psychic function, or convulsive movements." [HPO:probinson]
Show

 HP:0001252 Muscular hypotonia "Muscular hypotonia is an abnormally low muscle tone (the amount of tension or resistance to movement in a muscle), often involving reduced muscle strength. Hypotonia is characterized by a diminished resistance to passive stretching." [HPO:curators]
Show

 HP:0001256 Mental retardation, mild "Mild mental retardation is defined as an intelligence quotient (IQ) in the range of 50-69." [HPO:curators]
Show

 HP:0001263 Developmental retardation "A delay in the achievement of motor or mental milestones manifested prior to age 18 and generally associated with lifelong mental and/or physical impairments." [HPO:curators]
Show

 HP:0001328 Learning disability 
Show

 HP:0001999 Facial dysmorphism 
Show

 HP:0002007 Frontal bossing "The presence of an unusually prominent forehead." [HPO:curators]
Show

 HP:0002342 Mental retardation, moderate "Moderate mental retardation is defined as an intelligence quotient (IQ) in the range of 35-49." [HPO:curators]
Show

 HP:0003812 Phenotypic variability 
Show

 HP:0003829 Incomplete penetrance 
Show

 HP:0004209 Clinodactyly of the 5th finger "Clinodactyly refers to a bending or curvature of the `fifth finger` (FMA:24949) in the radial direction (i.e., towards the 4th finger)." [HPO:curators]
Show

 HP:0004322 Decreased body height "A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms)." [HPO:curators]
Show

 HP:0005274 Prominent nasal tip 
Show

 HP:0007018 Attention deficit hyperactivity disorder "Attention deficit hyperactivity disorder (ADHD) manifests at age 2-3 years or by first grade at the latest. The main symptoms are distractibility, impulsivity, hyperactivity, and often trouble organizing tasks and projects, difficulty going to sleep, and social problems from being aggressive, loud, or impatient." [HPO:curators]
Show

 HP:0007302 Bipolar affective disorder 
Show

 HP:0008050 Abnormality of the palpebral fissures 
Show

 HP:0010864 Mental retardation, severe "Moderate mental retardation is defined as an intelligence quotient (IQ) in the range of 20-34." [HPO:probinson]
Show

 HP:0030680 Abnormality of cardiovascular system morphology "Any structural anomaly of the heart and great vessels." []
Show

 HP:0100753 Schizophrenia "A mental disorder characterized by a disintegration of thought processes and of emotional responsiveness. It most commonly manifests as auditory hallucinations, paranoid or bizarre delusions, or disorganized speech and thinking, and it is accompanied by significant social or occupational dysfunction. The onset of symptoms typically occurs in young adulthood, with a global lifetime prevalence of about 0.3-0.7%." [HPO:sdoelken]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
No match






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr